Chinese Journal of Natural Medicines(2025年09期)
中國天然藥物(英文版)

目 錄

• Research progress on polysaccharides from medicine and food homology materials in functional foods
• Natural products targeting NLRP3 inflammasome for metabolic dysfunction-associated fatty liver disease:the known unknowns
• Leveraging microbial natural products for pharmaceutical innovation:a vision of inspiration and future prospects
• Jasurolignoside from Ilex pubescens exerts a therapeutic effect on acute lung injury in vitro and in vivo by binding to TLR4
• TSZAF monomer combination downregulates the Wnt/β-catenin signaling pathway and inhibits neutrophil recruitment to prevent lung cancer metastasis
• Caerulomycin A disrupts glucose metabolism and triggers ER stress-induced apoptosis in triple-negative breast cancer cells
• Multidrug resistance reversal effect of tenacissoside I through impeding EGFR methylation mediated by PRMT1 inhibition
• Discovery of bioactive polycyclic polyprenylated acylphloroglucinol from Hypericum patulum that protects against hepatic ischemia/reperfusion injury
• Anti-inflammatory and hepatoprotective triterpenoids from the traditional Mongolian medicine Gentianopsis barbata
• Structurally diverse terpenoids from Pseudotsuga brevifolia and their inhibitory effects against ACL and ACC1 enzymes
• Isodons A-H, seco-abietane and abietane-type diterpenoids from Isodon lophanthoides: isolation, structural elucidation, and anti-cholestatic activity
• Azaphilone derivatives with RANKL-induced osteoclastogenesis inhibition from the mangrove endophytic fungus Diaporthe sp.
• 《中國天然藥物》入選“中國科技期刊卓越行動計劃”獲國家六部委“國際影響力提升計劃”重點支持 全球?qū)W科排名第6位